You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Doxorubicin

Showing 51 - 75 of 2,767
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)

Not yet recruiting
  • Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 19, 2022

Concurrent Paclitaxel and Radiotherapy After Adjuvant

Not yet recruiting
  • Breast Cancer
  • Concurrent chemoradiation
  • (no location specified)
Oct 16, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Sarcoma Trial in Boston (Bevacizumab, Doxorubicin, Radiation Therapy)

Active, not recruiting
  • Sarcoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 6, 2022

Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

Not yet recruiting
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +13 more
  • (no location specified)
Feb 2, 2023

Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston

Active, not recruiting
  • Metastatic Urothelial Carcinoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Basal Cell Carcinoma Trial in West Palm Beach, New York (Doxorubicin-containing MNA, Placebo-containing MNA)

Recruiting
  • Basal Cell Carcinoma
  • Doxorubicin-containing MNA
  • Placebo-containing MNA
  • West Palm Beach, Florida
  • +1 more
Aug 10, 2022

Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal

Recruiting
  • Platinum-Refractory Fallopian Tube Carcinoma
  • +11 more
  • Copanlisib Hydrochloride
  • +4 more
  • Aurora, Colorado
  • +2 more
Dec 8, 2022

Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Invasive Breast Carcinoma
  • Triple-Negative Breast Carcinoma
  • Bevacizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 18, 2022

Soft Tissue Sarcoma Trial in Worldwide (Onfekafusp alfa, Doxorubicin)

Recruiting
  • Soft Tissue Sarcoma
  • Onfekafusp alfa
  • Doxorubicin
  • Bad Saarow, Germany
  • +8 more
Apr 8, 2022

Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
Jan 20, 2022

Metastatic Soft-tissue Sarcoma Trial in United States (NOX66, Doxorubicin)

Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Duarte, California
  • +3 more
Jul 12, 2022

Soft Tissue Sarcoma Trial in Santa Monica (L19TNF, DOXORUBICIN)

Active, not recruiting
  • Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Research Center (SORC) Cancer Center of Souther
Apr 19, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma, Advanced Leiomyosarcoma Trial in Boston (Lurbinectedin,

Recruiting
  • Advanced Soft-tissue Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Sarcoma Trial in Baltimore, Minneapolis (biological, drug, procedure, radiation)

Active, not recruiting
  • Sarcoma
  • pegfilgrastim
  • +5 more
  • Baltimore, Maryland
  • +1 more
Mar 25, 2022

Breast Cancer Trial in Paris, Barcelone, Madrid (Trastuzumab and non-pegylated liposomal doxorubicin)

Completed
Has Results
  • Breast Cancer
  • Trastuzumab and non-pegylated liposomal doxorubicin
  • Paris, France
  • +3 more
Feb 8, 2022

Adult T-cell Leukemia/Lymphoma, Extranodal NK-/T-cell Lymphoma, Nasal Type, Enteropathy-Associated T-Cell Lymphoma Trial run by

Not yet recruiting
  • Adult T-cell Leukemia/Lymphoma
  • +4 more
  • CC-486 (5-azacitidine)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Anthracycline Related Cardiotoxicity in Breast Cancer Trial in Lubbock (sulforaphane, Placebo Oral Tablet)

Recruiting
  • Anthracycline Related Cardiotoxicity in Breast Cancer
  • Lubbock, Texas
    Texas Tech University Health Sciences Center
Jul 18, 2022

Breast Cancer Trial in Shanghai (sintilimab, bevacizumab biosimilar, pegylated liposomal doxorubicin)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 22, 2022

Locally Advanced or Metastatic Solid Tumors Trial in China (IN10018+PLD, IN10018+PLD+Toripalimab)

Active, not recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Anyang, Henan, China
  • +6 more
Apr 25, 2023

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

Advanced Ovarian Cancer Trial in Spain (Olaparib, Pegylated Liposomal Doxorubicin)

Completed
  • Advanced Ovarian Cancer
  • Sabadell, Barcelona, Spain
  • +7 more
Jan 25, 2023

Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

Completed
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • Tucson, Arizona
  • +1 more
Jan 9, 2023

Leiomyosarcoma Trial in United States (Doxorubicin, L19TNF plus doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Doxorubicin
  • L19TNF plus doxorubicin
  • Phoenix, Arizona
  • +7 more
Apr 7, 2022

Pancreas Cancer Trial in Scottsdale, Morristown, Milwaukee (L-DOS47, Doxorubicin)

Recruiting
  • Pancreas Cancer
  • L-DOS47
  • Doxorubicin
  • Scottsdale, Arizona
  • +2 more
Mar 16, 2022